Prasco Labs Ships Zegerid Generic Version

Zegerid, a registered trademark of Santarus, is known to contain omeprazole, a proton pump inhibitor (PPI), and sodium bicarbonate, an antacid, which raises the gastric pH and thus protects omeprazole from acid degradation.

Zegerid is used to treat ulcers, gastroesophageal reflux disease (GERD), and other conditions involving excessive stomach acid production.

As per the terms of the supply agreement with Santarus, Prasco is expected to sell and distribute the capsule form of omeprazole/sodium bicarbonate in 20mg and 40mg strengths in the US under the Prasco label.

Santarus and Prasco claimed that omeprazole/sodium bicarbonate is AB-rated, therapeutically equivalent and substitutable for the brand Zegerid.

Thomas Arington, CEO of Prasco, said: “We are proud to establish this relationship with Santarus and to bring the authorised generic of Zegerid to consumers.”